Peter Sheldrake

1.6k total citations
41 papers, 856 citations indexed

About

Peter Sheldrake is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Peter Sheldrake has authored 41 papers receiving a total of 856 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Organic Chemistry, 18 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in Peter Sheldrake's work include Asymmetric Synthesis and Catalysis (8 papers), Synthesis of heterocyclic compounds (5 papers) and Synthesis and Reactions of Organic Compounds (5 papers). Peter Sheldrake is often cited by papers focused on Asymmetric Synthesis and Catalysis (8 papers), Synthesis of heterocyclic compounds (5 papers) and Synthesis and Reactions of Organic Compounds (5 papers). Peter Sheldrake collaborates with scholars based in United Kingdom and United States. Peter Sheldrake's co-authors include Edward McDonald, Paul Workman, Daniel J. Brunelle, Robert Lett, E. J. Corey, Lawrence S. Melvin, King Kuok Hii, Michael B. Hursthouse, K. C. Nicolaou and John R. Falck and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and PLoS ONE.

In The Last Decade

Peter Sheldrake

36 papers receiving 829 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Sheldrake United Kingdom 17 530 322 116 85 67 41 856
Anne Mengel Germany 12 623 1.2× 414 1.3× 79 0.7× 88 1.0× 58 0.9× 18 967
Mary M. Mader United States 16 601 1.1× 529 1.6× 64 0.6× 99 1.2× 41 0.6× 24 1.1k
Hitesh J. Sanganee United Kingdom 23 741 1.4× 592 1.8× 64 0.6× 100 1.2× 70 1.0× 37 1.3k
Takeshi Ogita Japan 18 389 0.7× 504 1.6× 149 1.3× 45 0.5× 141 2.1× 32 905
Keith W. Woods United States 19 789 1.5× 613 1.9× 109 0.9× 164 1.9× 83 1.2× 30 1.3k
Tsunehiko Soga Japan 16 420 0.8× 307 1.0× 52 0.4× 207 2.4× 46 0.7× 36 711
Andrei W. Konradi United States 14 328 0.6× 298 0.9× 220 1.9× 63 0.7× 37 0.6× 27 754
James Dowden United Kingdom 18 418 0.8× 437 1.4× 57 0.5× 65 0.8× 21 0.3× 34 1.0k
Jenny Roy Canada 17 250 0.5× 333 1.0× 53 0.5× 123 1.4× 50 0.7× 61 790
Robert D. Hubbard United States 16 653 1.2× 308 1.0× 40 0.3× 130 1.5× 67 1.0× 24 900

Countries citing papers authored by Peter Sheldrake

Since Specialization
Citations

This map shows the geographic impact of Peter Sheldrake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Sheldrake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Sheldrake more than expected).

Fields of papers citing papers by Peter Sheldrake

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Sheldrake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Sheldrake. The network helps show where Peter Sheldrake may publish in the future.

Co-authorship network of co-authors of Peter Sheldrake

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Sheldrake. A scholar is included among the top collaborators of Peter Sheldrake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Sheldrake. Peter Sheldrake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Frame, Sheelagh, Craig MacKay, Butrus Atrash, et al.. (2020). Fadraciclib (CYC065), a novel CDK inhibitor, targets key pro-survival and oncogenic pathways in cancer. PLoS ONE. 15(7). e0234103–e0234103. 64 indexed citations
2.
Sheldrake, Peter, et al.. (2017). Dynamic Equilibrium of the Aurora A Kinase Activation Loop Revealed by Single‐Molecule Spectroscopy. Angewandte Chemie International Edition. 56(38). 11409–11414. 33 indexed citations
3.
Sheldrake, Peter, et al.. (2017). Dynamic Equilibrium of the Aurora A Kinase Activation Loop Revealed by Single‐Molecule Spectroscopy. Angewandte Chemie. 129(38). 11567–11572. 3 indexed citations
4.
Platt, Georgina, S. Elaine Barrie, Georgia Zoumpoulidou, et al.. (2012). Mechanism-Based Screen for G1/S Checkpoint Activators Identifies a Selective Activator of EIF2AK3/PERK Signalling. PLoS ONE. 7(1). e28568–e28568. 86 indexed citations
5.
Westwood, Isaac M., et al.. (2012). Benzimidazole inhibitors of the protein kinase CHK2: Clarification of the binding mode by flexible side chain docking and protein–ligand crystallography. Bioorganic & Medicinal Chemistry. 20(22). 6630–6639. 9 indexed citations
6.
Wilson, Stuart C., Butrus Atrash, Clare Barlow, et al.. (2011). Design, synthesis and biological evaluation of 6-pyridylmethylaminopurines as CDK inhibitors. Bioorganic & Medicinal Chemistry. 19(22). 6949–6965. 26 indexed citations
7.
Large, Jonathan M., Florence I. Raynaud, Paul A. Clarke, et al.. (2010). Preparation and evaluation of trisubstituted pyrimidines as phosphatidylinositol 3-kinase inhibitors. 3-Hydroxyphenol analogues and bioisosteric replacements. Bioorganic & Medicinal Chemistry. 19(2). 836–851. 17 indexed citations
8.
9.
Atrash, Butrus, et al.. (2006). Synthesis of resorcinylic macrocycles related to radicicol via ring-closing metathesis. Tetrahedron Letters. 47(13). 2241–2243. 13 indexed citations
10.
Sheldrake, Peter, Mizio Matteucci, & Edward McDonald. (2006). Facile Generation of a Library of 5‐Aryl‐2‐arylsulfonyl‐1,3‐thiazoles.. ChemInform. 37(25). 2 indexed citations
11.
Atrash, Butrus, et al.. (2006). Development of synthetic routes to macrocyclic compounds based on the HSP90 inhibitor radicicol. Tetrahedron Letters. 47(13). 2237–2240. 9 indexed citations
12.
Sheldrake, Peter, N. Whittall, Andrew J. P. White, et al.. (2005). Conformation Analyses, Dynamic Behavior and Amide Bond Distortions of Medium-sized Heterocycles. 1. Partially and Fully Reduced 1-Benzazepines. The Journal of Organic Chemistry. 70(5). 1545–1551. 65 indexed citations
13.
Donohoe, Timothy J., Andrew J. McRiner, Madeleine Helliwell, & Peter Sheldrake. (2001). Use of dissolving metals in the partial reduction of pyridines: formation of 2-alkyl-1,2-dihydropyridines. Journal of the Chemical Society Perkin Transactions 1. 1435–1445. 20 indexed citations
14.
Sheldrake, Peter, et al.. (1997). Preparation of 5-Hydroxy-2-iodopyridine:  A Refutation of Earlier Reports. The Journal of Organic Chemistry. 62(9). 3008–3009. 3 indexed citations
15.
Sisko, Joseph, Mark Mellinger, Peter Sheldrake, & Neil H. Baine. (1996). An efficient method for the synthesis of substituted TosMIC precursors. Tetrahedron Letters. 37(45). 8113–8116. 47 indexed citations
16.
Sheldrake, Peter. (1994). Chapter 7. Heterocyclic compounds. Annual Reports Section B (Organic Chemistry). 91. 207–207.
17.
Sheldrake, Peter. (1993). The Anion of 4-Dimethoxymethylpyridine. A Convenient Synthesis of Some 4-Pyridyl Ketones A convienient synthesis of some 4-pyridyl ketones. Synthetic Communications. 23(14). 1967–1971. 8 indexed citations
18.
Sheldrake, Peter. (1993). Chapter 7. Heterocyclic compounds. Annual Reports Section B (Organic Chemistry). 90. 179–179.
19.
LANTOS, I., Peter Sheldrake, & Andrew S. Wells. (1990). Novel cage compounds from inter- and intra-molecular Diels–Alder reactions of heteroaromatic azadienes and methyl coumalate with cyclo-octa-1,5-diene. Journal of the Chemical Society Perkin Transactions 1. 1887–1890. 6 indexed citations
20.
Battersby, Alan R., Peter Sheldrake, James Staunton, & D. Clive Williams. (1974). Stereochemical course of hydroxylation of dopamine by dopamine-β-hydroxylase (EC1.14.17.1). Journal of the Chemical Society Chemical Communications. 566–567. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne Mengel Breakdown of academic impact, for papers by Mary M. Mader Breakdown of academic impact, for papers by Hitesh J. Sanganee Breakdown of academic impact, for papers by Takeshi Ogita Breakdown of academic impact, for papers by Keith W. Woods Breakdown of academic impact, for papers by Tsunehiko Soga Breakdown of academic impact, for papers by Andrei W. Konradi Breakdown of academic impact, for papers by James Dowden Breakdown of academic impact, for papers by Jenny Roy Breakdown of academic impact, for papers by Robert D. Hubbard
Rankless by CCL
2026